Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.
Status:
Recruiting
Trial end date:
2023-08-22
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to evaluate the safety, tolerability, and efficacy of
NP-101 in treating high-risk participants who have tested positive for Covid-19. The main
question[s] it aims to answer are:
- To evaluate the safety of NP-101, as well as establish the maximum tolerated dose in
high risk Covid-19 positive patients.
Participants will [describe the main tasks participants will be asked to do, treatments
they'll be given and use bullets if it is more than 2 items]. If there is a comparison group:
Researchers will compare [insert groups] to see if [insert effects].